These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8206329

  • 1. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells.
    Lee AV, Darbre P, King RJ.
    Mol Cell Endocrinol; 1994 Mar; 99(2):211-20. PubMed ID: 8206329
    [Abstract] [Full Text] [Related]

  • 2. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ, Harris WH, Wang DY, Darbre PD.
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.
    Abdul-Wahab K, Corcoran D, Perachiotti A, Darbre PD.
    Cell Prolif; 1999 Oct; 32(5):271-87. PubMed ID: 10619489
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH.
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [Abstract] [Full Text] [Related]

  • 5. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
    Yang CQ, Zhan X, Hu X, Kondepudi A, Perdue JF.
    Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
    [Abstract] [Full Text] [Related]

  • 6. Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation.
    Corcoran D, Perachiotti A, Darbre PD.
    Cell Prolif; 1996 Sep; 29(9):479-93. PubMed ID: 8980655
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
    De Leon DD, Terry C, Asmerom Y, Nissley P.
    Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
    [Abstract] [Full Text] [Related]

  • 8. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA.
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of mature insulin-like growth factor (IGF)-II leads to growth arrest in Caco-2 human colon cancer cells.
    Kim EJ, Holthuizen PE, Kim J, Park JH.
    Growth Horm IGF Res; 2005 Feb; 15(1):64-71. PubMed ID: 15701574
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast growth factor-2 inhibits the maturation of pro-insulin-like growth factor-II (Pro-IGF-II) and the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in the human adrenocortical tumor cell line NCI-H295R.
    Boulle N, Gicquel C, Logié A, Christol R, Feige JJ, Le Bouc Y.
    Endocrinology; 2000 Sep; 141(9):3127-36. PubMed ID: 10965883
    [Abstract] [Full Text] [Related]

  • 11. Secretion of noncomplexed 'Big' (10-18 kD) forms of insulin-like growth factor-II by 12 soft tissue sarcoma cell lines.
    Elmlinger MW, Rauschnabel U, Koscielniak E, Weber K, Ranke MB.
    Horm Res; 1999 Sep; 52(4):178-85. PubMed ID: 10725783
    [Abstract] [Full Text] [Related]

  • 12. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II).
    De León DD, Issa N, Nainani S, Asmerom Y.
    Horm Metab Res; 1999 Sep; 31(2-3):142-7. PubMed ID: 10226795
    [Abstract] [Full Text] [Related]

  • 13. Does the overexpression of pro-insulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes?
    Hoeflich A, Wolf E, Braulke T, Koepf G, Kessler U, Brem G, Rascher W, Blum W, Kiess W.
    Eur J Biochem; 1995 Aug 15; 232(1):172-8. PubMed ID: 7556147
    [Abstract] [Full Text] [Related]

  • 14. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
    Mathieu M, Vignon F, Capony F, Rochefort H.
    Mol Endocrinol; 1991 Jun 15; 5(6):815-22. PubMed ID: 1656243
    [Abstract] [Full Text] [Related]

  • 15. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
    Brünner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ.
    Eur J Cancer; 1993 Jun 15; 29A(4):562-9. PubMed ID: 8435211
    [Abstract] [Full Text] [Related]

  • 16. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ.
    Mol Endocrinol; 1996 Mar 15; 10(3):286-97. PubMed ID: 8833657
    [Abstract] [Full Text] [Related]

  • 17. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W.
    J Cell Physiol; 1994 Jun 15; 159(3):531-41. PubMed ID: 8188767
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion.
    Lambert S, Carlisi A, Collette J, Franchimont P, Gol-Winkler R.
    Int J Cancer; 1992 Sep 30; 52(3):404-8. PubMed ID: 1399116
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N.
    Cancer Res; 1990 Jan 01; 50(1):48-53. PubMed ID: 2152773
    [Abstract] [Full Text] [Related]

  • 20. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
    Kiess W, Greenstein LA, Lee L, Thomas C, Nissley SP.
    Mol Endocrinol; 1991 Feb 01; 5(2):281-91. PubMed ID: 1645456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.